Reporting owner · CIK 0001693548
Culverwell Anthony James
Visual SEC Form 4 history across 1 companies, 4 transactions and 3 filings.
DIRQuoin Pharmaceuticals, Ltd.
Open-market mix
100%buys
Open-market buy performance
90-day forward return on this insider's open-market purchases
For every open-market buy (Form 4 code P, acquisition A) in the selected window, we take the closing price on the transaction date and 90 calendar days later, then compute the percentage change. The figures shown are the simple average and median of those per-buy returns.
- Window follows the rest of the summary (all-history or last 3 months).
- Only buys with a resolved price context are counted.
- Includes both positive and negative outcomes; gains and losses net out at the per-buy level.
Monthly open-market activity
Reported purchase and sale transaction counts
Buys Sells
Net value flow
Buys minus sells
Feb 26
$0
Aug 26
—
Transaction texture
Ownership and ticket size
Average P/S size—
Median P/S size—
Direct4
Indirect0
Aug 31, 2026buy
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
Latest transaction
buy at Quoin Pharmaceuticals, Ltd. on Aug 31, 2026 with an unknown reported value.
Review SEC filingLatest buy
buy at Quoin Pharmaceuticals, Ltd. on Aug 31, 2026 with an unknown reported value.
Review SEC filingLatest sale
No open-market insider sale is available.
Associated companies
Visual map of known reporting history
| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| QNRX | Culverwell Anthony James | DIR | buy | 3.07k | — | P | 0.0% | 09/02 | 08/31 | |
| QNRX | Culverwell Anthony James | DIR | buy | 6.14k | $2.99M | P | 0.0% | 09/02 | 08/31 | |
| QNRX | Culverwell Anthony James | DIR | grant | 31.3k | $16.1M | A | — | 08/28 | 08/27 | |
| QNRX | Culverwell Anthony James | DIR | grant | 21.7k | $0 | A | −10.8% | 02/06 | 02/04 |
Culverwell Anthony James Insider Activity FAQ
SEC Form 4 context
Who is Culverwell Anthony James?
Culverwell Anthony James is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001693548.
Which companies has Culverwell Anthony James reported transactions for?
Quoin Pharmaceuticals, Ltd.
When was Culverwell Anthony James's latest insider buy?
buy at Quoin Pharmaceuticals, Ltd. on Aug 31, 2026 with an unknown reported value.
When was Culverwell Anthony James's latest insider sale?
No open-market insider sale is available for this period.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.